EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Dissecting the immune infiltrate of primary luminal B‐like breast carcinomas in relation to age

Sigrid Hatse, Yentl Lambrechts, Asier Antoranz Martinez, Maxim De Schepper, Tatjana Geukens, Hanne Vos iD, Lieze Berben, Julie Messiaen, Lukas Marcelis, Yannick Van Herck, Patrick Neven, Ann Smeets und 5 weitere

The Journal of Pathology · 2024-11 · 264 (3) · 344-356

DOI: 10.1002/path.6354 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pathology, online erschienen am 29.09.2024. Verfasst von Sigrid Hatse und 16 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Breast Neoplasms, Lymphocytes, Tumor-Infiltrating. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Emmanuel Van der Schueren, Fonds Voor Wetenschappelijk Onderzoek Vlaanderen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The impact of aging on the immune landscape of luminal breast cancer (Lum‐BC) is poorly characterized. Understanding the age‐related dynamics of immune editing in Lum‐BC is anticipated to improve the therapeutic benefit of immunotherapy in older patients. To this end, here we applied the ‘multiple iterative labeling by antibody neo‐deposition’ (MILAN) technique, a spatially resolved single‐cell multiplex immunohistochemistry method. We created tissue microarrays by sampling both the tumor center and invasive front of luminal breast tumors collected from a cohort of treatment‐naïve patients enrolled in the prospective monocentric IMAGE (IMmune system and AGEing) study. Patients were subdivided into three nonoverlapping age categories (35–45 = ‘young’, n = 12; 55–65 = ‘middle’, n = 15; ≥70 = ‘old’, n = 26). Additionally, depending on localization and amount of cytotoxic T lymphocytes, the tumor immune types ‘desert’ ( n = 22), ‘excluded’ ( n = 19), and ‘inflamed’ ( n = 12) were identified. For the MILAN technique we used 58 markers comprising phenotypic and functional markers allowing in‐depth characterization of T and B lymphocytes (T&B‐lym). These were compared between age groups and tumor immune types using Wilcoxon's test and Pearson's correlation. Cytometric analysis revealed a decline of the immune cell compartment with aging. T&B‐lym were numerically less abundant in tumors from middle‐aged and old compared to young patients, regardless of the geographical tumor zone. Likewise, desert‐type tumors showed the smallest immune‐cell compartment and were not represented in the group of young patients. Analysis of immune checkpoint molecules revealed a heterogeneous geographical pattern of expression, indicating higher numbers of PD‐L1 and OX40‐positive T&B‐lym in young compared to old patients. Despite the numerical decline of immune infiltration, old patients retained higher expression levels of OX40 in T helper cells located near cancer cells, compared to middle‐aged and young patients. Aging is associated with important numerical and functional changes of the immune landscape in Lum‐BC. © 2024 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsLymphocytes, Tumor-InfiltratingHumansFemaleMiddle AgedAgedAdultAge FactorsBiomarkers, TumorTumor MicroenvironmentImmunohistochemistryB-LymphocytesProspective StudiesTissue Array AnalysisAged, 80 and over

Stichwörter der Autor:innen

(luminal) breast canceragingbreast cancer biologyimmune infiltrationmultiplex immunohistochemistryspatial proteomicstumor (immune) microenvironment

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Laboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, Leuven, Belgium.
  • Laboratory for Translational Cell and Tissue Research, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
  • Laboratory for Translational Breast Cancer Research (LTBCR), Department of Oncology, KU Leuven, Leuven, Belgium.
  • Department of Surgical Oncology, University Hospitals Leuven/KU Leuven, Leuven, Belgium.
  • Multidisciplinary Breast Center, University Hospitals Leuven, Leuven, Belgium.
  • Department of Pathology, University Hospitals Leuven, Leuven, Belgium.

ORCID-Profile: Hanne Vos, Christine Desmedt, Frederik De Smet, Giuseppe Floris

Förderung

  • Emmanuel Van der Schueren
  • Fonds Voor Wetenschappelijk Onderzoek Vlaanderen

Zitieren

APA

Hatse, S., Lambrechts, Y., Antoranz Martinez, A., De Schepper, M., Geukens, T., Vos, H., Berben, L., Messiaen, J., Marcelis, L., Van Herck, Y., Neven, P., Smeets, A., Desmedt, C., De Smet, F., Bosisio, F. M., Wildiers, H., & Floris, G. (2024). Dissecting the immune infiltrate of primary luminal B‐like breast carcinomas in relation to age. The Journal of Pathology, 264(3), 344-356. https://doi.org/10.1002/path.6354

Vancouver

Hatse S, Lambrechts Y, Antoranz Martinez A, De Schepper M, Geukens T, Vos H, et al. Dissecting the immune infiltrate of primary luminal B‐like breast carcinomas in relation to age. The Journal of Pathology. 2024;264(3):344-356. doi:10.1002/path.6354

BibTeX
@article{Hatse2024,
  author = {Hatse, Sigrid and Lambrechts, Yentl and Antoranz Martinez, Asier and De Schepper, Maxim and Geukens, Tatjana and Vos, Hanne and Berben, Lieze and Messiaen, Julie and Marcelis, Lukas and Van Herck, Yannick and Neven, Patrick and Smeets, Ann and Desmedt, Christine and De Smet, Frederik and Bosisio, Francesca Maria and Wildiers, Hans and Floris, Giuseppe},
  title = {Dissecting the immune infiltrate of primary luminal B‐like breast carcinomas in relation to age},
  journal = {The Journal of Pathology},
  year = {2024},
  volume = {264},
  number = {3},
  pages = {344--356},
  doi = {10.1002/path.6354}
}
Kostenlos starten →